http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2461828-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_915a8bd1b68662600e20113af3ab290f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B10-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e70cecb16c793eb275b1306cbce7d227 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58d80651cd1517f8292f96656fc5d3f8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad2ca17d8a03a4449fae6cdb101c73ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d77f694a110207f1905ce4d7fdaa13 |
| publicationDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2461828-C1 |
| titleOfInvention | Diagnostic technique for atopic dermatitis in children |
| abstract | FIELD: medicine. n SUBSTANCE: stage of atopic dermatitis in children is diagnosed by immunobiological assay of patient's peripheral blood. A degree of lymphocyte expression of CD95 + markers is evaluated. If the CD95 + value exceeds 60.09% enables diagnosing an acute stage of the disease, while the CD95 + values 20.33% to 60.09% shows a chronic stage. n EFFECT: well-timed prediction of the clinical course ensured by accuracy and acceleration of dianosis of transmission of the acute stage of atopic dermatitis in children into the chronic stage. n 1 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2772411-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2784352-C1 |
| priorityDate | 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.